Medical technology management: Bridging the gap between theory and practice

Israel Medical Association Journal

Volumn 7, Issue 4, 2005, Pages 211-215

  Shemer, Joshua ^a,b   Abadi Korek, Ifat ^a   Seifan, Alon ^c  

^a GERTNER INSTITUTE FOR EPIDEMIOLOGY AND HEALTH POLICY RESEARCH   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

^c MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

Economic evaluation; Health technology assessment; Pharmacoeconomics; Resource allocation

Indexed keywords

ARTICLE; ECONOMIC EVALUATION; GOVERNMENT; HEALTH CARE COST; HEALTH CARE PLANNING; HEALTH CARE POLICY; ISRAEL; MEDICAL TECHNOLOGY; RESOURCE ALLOCATION; RESOURCE MANAGEMENT;

BIOMEDICAL TECHNOLOGY; HEALTH CARE COSTS; HEALTH CARE RATIONING; HEALTH CARE REFORM; HUMANS; TECHNOLOGY ASSESSMENT, BIOMEDICAL;

EID: 17244366123     PISSN: 15651088     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Jonsson B. Economic evaluation of health care technologies. Acta Endocrinol 1993;128(Suppl 2):50-4.
2. Maynard A, McDaid D. Evaluating health interventions: exploiting the potential. Health Policy 2003;63:215-26.
3. Cookson R, Hutton J. Regulating the economic evaluation of pharmaceuticals and medical devices: a European perspective. Health Policy 2003;63:167-78.
4. Perry S, Gardner E, Thamer M. Status of health technology assessment worldwide. Int J Technol Assess Health Care 1997;13:81-98.
5. Perry S, Thamer M. Health technology assessment: decentralize and fragmented in the U.S. compared to other countries. Health Policy 1997;42:269-90.
6. Hutubessy R, Chisholm D, Edejer TT. Generalized cost-effectiveness analysis for national-level priority-setting in the health sector. Cost Eff Resour Alloc 2003;1:8.
7. Hailey D. Australian economic evaluation and government decisions on pharmaceuticals, compared to assessment of other health technologies. Soc Sci Med 1997;45:563-81.
8. Palmer S, Torgerson D. Definitions of efficiency. Br Med J 1999;318:1136.
9. Raftery J. Economic evaluation: an introduction. Br Med J 1998;316:1013-14.
10. Holohan TV. The federal role in health technology assessment. Lancet 1996;348:9033.
11. Hoffman C, Graf von der Schulenberg JM. The influence of economic evaluation studies on decision making. A European survey. Health Policy 2000;52:179-92.
12. Bloom BS. Use of formal benefit/cost evaluations in health system decision making. Am J Manag Care 2004;10:329-35.
13. Birch S, Gafni A. Economics and the evaluation of health care programmes: generalisability of methods and implications for generalisability of results. Health Policy 2003;64:207-19.
14. Ramsey SD, McIntosh M, Sullivan SD. Design issues for conducting cost-effectiveness analyses alongside clinical trials. Annu Rev Public Health 2001;22:129-41.
15. Cohen BJ. Discounting in cost-utility analysis of healthcare interventions: reassessing current practice. Pharmacoeconomics 2003;21:75-87.
16. Lazaro A. Theoretical arguments for the discounting of health consequences: where do we go from here? Pharmacoeconomics 2002;20:943-61.
17. Ortendahl M, Fries JF. Time-related issues with application to health gains and losses. J Clin Epidemiol 2002;55:843-8.
18. Towse A, Pritchard C. National Institute for Clinical Excellence (NICE): Is economic appraisal working? Pharmacoeconomics 2002;20(Suppl 3):95-105.
19. Millbank Memorial Fund. Better Information, Better Outcomes? The Use of Health Technology Assessment and Clinical Effectiveness Data in Health Care Purchasing Decisions in the United Kingdom and the United States. New York: Millbank Memorial Fund, 2000.
20. Prosser L, Koplan J, Neumann P, Weinstein M. Barriers to using cost-effectiveness analysis in managed care decision making. Am J Manag Care 1999;6:173-9.
21. Office of Technology Assessment. Health Care Technology and its Assessment in Eight Countries, Washington, DC: US Government Printing Office, 1995.
22. Neumann PJ. Why don't Americans use cost-effectiveness analysis? Am J Manag Care 2004;10:308-12.
23. Kim M, Blendon R, Benson J. How interested are Americans in new medical technologies? A multicountry comparison. Health Aff 2001;20:194-201.
24. Tan-Torres Edejer T, Baltussen R, Adam T, et al. Making Choices in Health: WHO Guide to Cost-Effectiveness Analysis. Geneva: World Health Organization. http://www3.who.int/whosis/cea/background_documents/pdf/guidelines.pdf. Accessed June 2004.
25. Eisenberg JM, Zarin D. Health technology assessment in the United States. Past, present and future. Int J Technol Assess Health Care 2002;18:192-8.
26. Jonsson E. Development of health technology assessment in Europe. Int J Technol Assess Health Care 2002;18:171-83.
27. SDO. The NHS Service Delivery and Organisation Research & Development Programme. Available at: http://www.sdo.lshtm.ac.uk/ Accessed June 2004.
28. Jefferson T, Demicheli V. Quality of economic evaluations in health care. Br Med J 2002;324:313-14.
29. Jefferson T, Demicheli V, Vale L. Quality of systematic reviews of economic evaluations in health care. JAMA 2002;287:2809-12.
30. O'Brien BJ, Briggs AH. Analysis of uncertainty in health care cost-effectiveness studies: an introduction to statistical issues and methods. Stat Methods Med Res 2002;11:455-68.
31. Tsuchiya A. Age-related preferences and age weighting health benefits. Soc Sci Med 1999;48:267-76.
32. Powers M, Faden R. Inequalities in health, inequalities in health care: four generations of discussion about justice and cost-effectiveness analysis. Kennedy Inst Ethics J 2000;10:109-27.
33. Schwappach DL. Resource allocation, social values and the QALY: a review of the debate and empirical evidence. Health Expect 2002;5:210-22.
34. Williams A. cost-effectiveness analysis: is it ethical? J Med Ethics 1992;18:7-11.
35. Ubel PA, Richardson J, Menzel P. Societal value, the person trade-off, and the dilemma of whose values to measure for cost-effectiveness analysis. Health Econ 2000;9:127-36.
36. Menzel P, Gold MR, Nord E, et al. Toward a broader view of values in cost-effectiveness analysis of health. Hastings Cent Rep 1999;29:7-15.
37. Slowther A, Hope T. Resource allocation decisions in U.K. healthcare: do ethics committees have a role? HEC Forum 2002;14:64-72.
38. Shani S, Siebzehner MI, Luxenburg O, Shemer J. Setting priorities for the adoption of health technologies on a national level - the Israeli experience. Health Policy 2000;54:169-85.